Gossamer Bio, Inc.
GOSS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $114,701 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $114,701 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $138,487 | $135,304 | $170,919 | $170,267 |
| G&A Expenses | $36,133 | $38,455 | $47,609 | $45,782 |
| SG&A Expenses | $36,133 | $38,455 | $47,609 | $45,782 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $10,000 | $65 | $75 |
| Operating Expenses | $174,620 | $183,759 | $218,593 | $216,124 |
| Operating Income | -$59,919 | -$183,759 | -$218,593 | -$216,124 |
| % Margin | -52.2% | – | – | – |
| Other Income/Exp. Net | $4,284 | $3,942 | -$10,785 | -$17,880 |
| Pre-Tax Income | -$55,635 | -$179,817 | -$229,378 | -$234,004 |
| Tax Expense | $893 | $0 | $0 | $0 |
| Net Income | -$56,528 | -$179,817 | -$229,378 | -$234,004 |
| % Margin | -49.3% | – | – | – |
| EPS | -0.25 | -0.8 | -2.84 | -3.33 |
| % Growth | 68.8% | 71.8% | 14.7% | – |
| EPS Diluted | -0.25 | -1.18 | -2.84 | -3.33 |
| Weighted Avg Shares Out | 226,228 | 225,572 | 84,575 | 74,843 |
| Weighted Avg Shares Out Dil | 226,228 | 225,572 | 84,575 | 74,843 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,779 | $1,997 | $1,583 | $761 |
| Interest Expense | $11,517 | $13,511 | $13,880 | $19,440 |
| Depreciation & Amortization | $4,151 | $4,385 | $4,429 | $5,167 |
| EBITDA | -$39,967 | -$161,921 | -$211,069 | -$209,397 |
| % Margin | -34.8% | – | – | – |